Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1037, pseudogene (RNU6-1037P)
- Target
- RNU6-1037P
- Molecular classification
- Processed pseudogene, Non-coding RNA-derived pseudogene, Small nuclear RNA (snRNA)-related pseudogene
01
Overview
RNU6-1037P is a processed pseudogene derived from the U6 small nuclear RNA gene, identified in the human genome as a non-functional, non-coding sequence that does not produce functional RNA or protein[1][2][4]. U6 small nuclear RNA (snRNA) proper is highly conserved and plays a vital role in spliceosomal complex formation, catalyzing intron removal during mRNA processing[3][5]. However, pseudogenes like RNU6-1037P result from genomic retrotransposition events and reflect evolutionary history without contributing to cell physiology or pathology[4][6]. There is no evidence this pseudogene has biological, therapeutic, or pathological relevance, nor does it serve as a biomarker or interact with drugs.
- Other names
- RNU6-1037PRNA, U6 small nuclear 1037, pseudogene
02
Mechanism of action
None (as a pseudogene, it is not a druggable entity or target for mechanisms of action)
03
Biological functions
None (as a pseudogene, it lacks direct biological function—functional U6 snRNA is involved in mRNA splicing, but pseudogenes do not partake in this process)
04
Disease associations
None established (no direct disease association or roles have been reported for this pseudogene variant)
05
Safety considerations
None applicable; not a therapeutic target
Beyond the preview
Go deeper on RNA, U6 small nuclear 1037, pseudogene (RNU6-1037P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 1037, pseudogene (RNU6-1037P).